Picture of Humanigen logo

HGENQ — Humanigen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Humanigen Inc reports results for the quarter ended in March - Earnings Summary

* Humanigen Inc  HGEN.OQ  reported a quarterly adjusted loss of
$1.25​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 64
cents per share.
* Revenue was $486.00 thousand​;  analysts expected zero. 
* Humanigen Inc's reported EPS for the quarter was a loss of
$1.25​.
* The mean earnings estimate of analysts had fallen by
about 64.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Humanigen Inc shares had fallen by 10.9% this quarter and
lost 2.7% so far this year.
* The company reported a quarterly loss of $65.57 million.
* Wall Street's median 12-month price target for Humanigen Inc
is $36.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 14 at 02:33 a.m. GMT.
​All figures in US dollars

Recent news on Humanigen

See all news